TH11239B - - Google Patents
Info
- Publication number
- TH11239B TH11239B TH9201001237A TH9201001237A TH11239B TH 11239 B TH11239 B TH 11239B TH 9201001237 A TH9201001237 A TH 9201001237A TH 9201001237 A TH9201001237 A TH 9201001237A TH 11239 B TH11239 B TH 11239B
- Authority
- TH
- Thailand
- Prior art keywords
- pharmaceutical
- tramadol
- mixtures
- approximately
- oxicodone
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims abstract 15
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims abstract 6
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 claims abstract 6
- 229960004380 tramadol Drugs 0.000 claims abstract 6
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims abstract 6
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 claims abstract 5
- 229960004126 codeine Drugs 0.000 claims abstract 3
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 claims 3
- 229960003107 tramadol hydrochloride Drugs 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940005483 opioid analgesics Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 abstract 2
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 abstract 2
- 229960000240 hydrocodone Drugs 0.000 abstract 2
- 230000000144 pharmacologic effect Effects 0.000 abstract 2
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 abstract 2
- 206010010774 Constipation Diseases 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 206010059866 Drug resistance Diseases 0.000 abstract 1
- 208000000059 Dyspnea Diseases 0.000 abstract 1
- 206010013975 Dyspnoeas Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940127240 opiate Drugs 0.000 abstract 1
- 208000013220 shortness of breath Diseases 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH13506A TH13506A (de) | 1993-12-15 |
| TH11239B true TH11239B (de) | 2001-11-12 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takemori et al. | Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone | |
| US3966940A (en) | Analgetic compositions | |
| US5352680A (en) | Delta opioid receptor antagonists to block opioid agonist tolerance and dependence | |
| KR930005617A (ko) | 트라마돌 및 코데인, 옥시코돈 또는 하이드로코돈을 함유하는 조성물 및 그의 용도 | |
| Portoghese et al. | TENA, a selective kappa opioid receptor antagonist | |
| NZ331001A (en) | Use of an opiate K receptor agonist as an antipruritic | |
| IL110436A (en) | Acylated tricyclic benzazepines and similar compounds, their preparation and pharmaceutical vasopressin antagonist compositions containing them | |
| Shook et al. | Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors. | |
| CA2045481A1 (en) | Immunosupressing agent and process of producing the same | |
| Zukin | Differing stereospecificities distinguish opiate receptor subtypes | |
| Hayes et al. | Determination of the receptor selectivity of opioid agonists in the guinea‐pig ileum and mouse vas deferens by use of β‐funaltrexamine | |
| Mao et al. | Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats | |
| US4416871A (en) | Inhibition by peptides of tolerance to and physical dependence on morphine | |
| Yoshimura et al. | Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum | |
| Sayre et al. | Alkylation of opioid receptor subtypes by. alpha.-chlornaltrexamine produces concurrent irreversible agonistic and irreversible antagonistic activities | |
| Altura et al. | Identification of benzomorphan-kappa opiate receptors in cerebral arteries which subserve relaxation | |
| Baxter et al. | Effect of a potent synthetic opioid pentapeptide in some anti-nociceptive and behavioural tests in mice and rats [proceedings] | |
| TH11239B (de) | ||
| TH13506A (de) | ||
| Gupta et al. | Chimeric peptide of Met-enkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception | |
| TAKAHASHI et al. | Distinctive implication of emotional factors in various types of stress-induced analgesia | |
| Schmidhammer et al. | Synthesis and Biological Evaluation of 14‐Alkoxymorphinans. Part 9. 14‐O‐ethyl‐5‐methylnaltrexone, and opioid antagonist with unusual selectivity | |
| Shook et al. | A cyclic somatostatin analog that precipitates withdrawal in morphine-dependent mice | |
| Miyamoto et al. | Relative involvement of supraspinal and spinal μ opioid receptors in morphine dependence in mice | |
| Olgiati et al. | Characterization of type 2 opiate receptors |